The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group
Abstract
Curative therapy for childhood cancer has improved significantly in the last 2 decades such that, at present, ∼80% of all children with cancer are likely to survive ≥5 years after diagnosis. Prevention, early diagnosis, and treatment of long-term sequelae of therapy have become increasingly more significant as survival rates continue to improve. Cardiovascular disease is a well-recognized cause of increased late morbidity and mortality among survivors of childhood cancer. The Children's Oncology Group Late Effects Committee and Nursing Discipline and Patient Advocacy Committee have recently developed guidelines for follow-up of long-term survivors of pediatric cancer. A multidisciplinary task force critically reviewed the existing literature to evaluate the evidence for the cardiovascular screening recommended by the Children's Oncology Group guidelines. In this review we outline the clinical manifestations of late cardiovascular toxicities, suggest modalities and frequency of monitoring, and address some of the controversial and unresolved issues regarding cardiovascular disease in childhood cancer survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Scottish Intercollegiate Guidelines Network
Twaddle, S., & Qureshi, S. (2005) · Evidence-based Healthcare and Public Health · doi:10.1016/j.ehbc.2005.09.008 · Cited by 4,084
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Self-citationRisk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Ruccione, K., Smithson, W. A., & Robison, L. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3163 · Cited by 798
Factors Affecting Late Mortality From Heart Disease After Treatment of Hodgkin's Disease
Hancock, S. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160067031 · Cited by 773
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
LEGHA, S. S., BENJAMIN, R. S., MACKAY, B., EWER, M., WALLACE, S., VALDIVIESO, M., RASMUSSEN, S. L., BLUMENSCHEIN, G. R., & FREIREICH, E. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-133 · Cited by 763
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 749
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., Hester, A. L., Darling, J., Armstrong, F. D., Blatt, J., Constine, L. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.032 · Cited by 706
Self-citationDoxorubicin cardiotoxicity: analysis of prevailing hypotheses
Olson, R. D., & Mushlin, P. S. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210154 · Cited by 690
Hull, M. C. (2003) · JAMA · doi:10.1001/jama.290.21.2831 · Cited by 644
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Doll, S. R. (1980) · Cancer · doi:10.1002/1097-0142(19800515)45:10<2475::aid-cncr2820451004>3.0.co;2-6 · Cited by 565
Aurigemma, G. P., Gottdiener, J. S., Shemanski, L., Gardin, J., & Kitzman, D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01110-x · Cited by 531
Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest Radiotherapy
Adams, M. J., Lipsitz, S. R., Colan, S. D., Tarbell, N. J., Treves, S. T., Diller, L., Greenbaum, N., Mauch, P., & Lipshultz, S. E. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.109 · Cited by 500
Self-citationTebbi, C. K., London, W. B., Friedman, D., Villaluna, D., De Alarcon, P. A., Constine, L. S., Mendenhall, N. P., Sposto, R., Chauvenet, A., & Schwartz, C. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3879 · Cited by 493
Gottdiener, J. S., McClelland, R. L., Marshall, R., Shemanski, L., Furberg, C. D., Kitzman, D. W., Cushman, M., Polak, J., Gardin, J. M., Gersh, B. J., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00006 · Cited by 480
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Constrictive Pericarditis in 26 Patients With Histologically Normal Pericardial Thickness
Talreja, D., Edwards, W. D., Danielson, G. K., Schaff, H. V., Tajik, A. J., Tazelaar, H. D., Breen, J. F., & Oh, J. K. (2003) · Circulation · doi:10.1161/01.cir.0000087606.18453.fd · Cited by 473
Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock, S. L., Donaldson, S. S., & Hoppe, R. T. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.7.1208 · Cited by 443
Amato, G. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1671 · Cited by 440
Daunomycin-induced cardiotoxicity in children and adults
Von Hoff, D. D., Rozencweig, M., Layard, M., Slavik, M., & Muggia, F. M. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90315-1 · Cited by 437
Stewart, J. R., Fajardo, L. F., Gillette, S. M., & Constine, L. S. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00656-6 · Cited by 403
Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study
Kremer, L. C. M., van Dalen, E. C., Offringa, M., Ottenkamp, J., & Voûte, P. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.191 · Cited by 399
Asymptomatic cardiac disease following mediastinal irradiation
Heidenreich, P. A., Hancock, S. L., Lee, B. K., Mariscal, C. S., & Schnittger, I. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00759-9 · Cited by 393
Carmel, R. J., & Kaplan, H. S. (1976) · Cancer · doi:10.1002/1097-0142(197606)37:6<2813::aid-cncr2820370637>3.0.co;2-s · Cited by 385
Increased Risk of Ischemic Stroke After Radiotherapy on the Neck in Patients Younger Than 60 Years
Dorresteijn, L. D. A., Kappelle, A. C., Boogerd, W. J., Klokman, W. J., Balm, A. J. M., Keus, R. B., van Leeuwen, F. E., & Bartelink, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.282 · Cited by 385
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384
Bowers, D. C., Liu, Y., Leisenring, W., McNeil, E., Stovall, M., Gurney, J. G., Robison, L. L., Packer, R. J., & Oeffinger, K. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2884 · Cited by 383
Kremer, L. C. M., van der Pal, H. J. H., Offringa, M., van Dalen, E. C., & Voûte, P. A. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf167 · Cited by 354
The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients
Gibney, J. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2596 · Cited by 324
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.022 · Cited by 299
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.
Ryberg, M., Nielsen, D., Skovsgaard, T., Hansen, J., Jensen, B. V., & Dombernowsky, P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3502 · Cited by 289
van Dalen, E. C., van der Pal, H. J. H., Kok, W. E. M., Caron, H. N., & Kremer, L. C. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.005 · Cited by 284
Taskinen, M., Saarinen-Pihkala, U. M., Hovi, L., & Lipsanen-Nyman, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02717-3 · Cited by 280
Stone, N. J., Bilek, S., & Rosenbaum, S. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.006 · Cited by 267
Screening for Coronary Artery Disease After Mediastinal Irradiation for Hodgkin's Disease
Heidenreich, P. A., Schnittger, I., Strauss, H. W., Vagelos, R. H., Lee, B. K., Mariscal, C. S., Tate, D. J., Horning, S. J., Hoppe, R. T., & Hancock, S. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.0805 · Cited by 262
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population
McDonagh, T. A. (2001) · Heart · doi:10.1136/heart.86.1.21 · Cited by 255
Adriamycin cardiotoxicity: a survey of 1273 patients.
Praga, C., Beretta, G., Pl, V., Gr, L., Pollini, C., Bonadonna, G., Canetta, R. M., Castellani, R., Villa, E., Cg, G., et al. (1979) · PubMed · Cited by 248
Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome
Talvensaari, K. K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.3051 · Cited by 237
Bowers, D. C., McNeil, D. E., Liu, Y., Yasui, Y., Stovall, M., Gurney, J. G., Hudson, M. M., Donaldson, S. S., Packer, R. J., Mitby, P. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.15.107 · Cited by 233
Self-citationRadiation-induced heart disease: An update
Robert Stewart, J., & Fajardo, L. F. (1984) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(84)90003-3 · Cited by 232
The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening
Wang, T. J., Levy, D., Benjamin, E. J., & Vasan, R. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00012 · Cited by 229
Adams, M. J., & Lipshultz, S. E. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20352 · Cited by 224
Self-citationLe Deley, M.-C., Leblanc, T., Shamsaldin, A., Raquin, M.-A., Lacour, B., Sommelet, D., Chompret, A., Cayuela, J.-M., Bayle, C., Bernheim, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.100 · Cited by 216
Late anthracycline cardiotoxicity after childhood cancer: A prospective longitudinal study
Sorensen, K., Levitt, G. A., Bull, C., Dorup, I., & Sullivan, I. D. (2003) · Cancer · doi:10.1002/cncr.11274 · Cited by 214
Structure of the adriamycin-cardiolipin complex
Goormaghtigh, E., Huart, P., Praet, M., Brasseur, R., & Ruysschaert, J.-M. (1990) · Biophysical Chemistry · doi:10.1016/0301-4622(90)80012-v · Cited by 200
Sorensen, K., Levitt, G., Bull, C., Chessells, J., & Sullivan, I. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.61 · Cited by 160
Wassmuth, R., Lentzsch, S., Erdbruegger, U., Schulz-Menger, J., Doerken, B., Dietz, R., & Friedrich, M. G. (2001) · American Heart Journal · doi:10.1067/mhj.2001.115436 · Cited by 160
Link, K., Moëll, C., Garwicz, S., Cavallin-Ståhl, E. K., Björk, J., Thilén, U., Åhrén, B., & Erfurth, E. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0126 · Cited by 155
Increased risk of cardiac dysfunction after anthracyclines in girls
Silber, J. H., Jakacki, R. I., Larsen, R. L., Goldwein, J. W., & Barber, G. (1993) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950210704 · Cited by 151
Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up
Reinders, J. G., Heijmen, B. J. M., Acht, M. J. J. O.-V., van Putten, W. L. J., & Levendag, P. C. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00026-2 · Cited by 148
Lauer, M. S., Evans, J. C., & Levy, D. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90052-z · Cited by 141
Green, D. M., Hyland, A. J., Chung, C. S., Zevon, M. A., & Hall, B. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3207 · Cited by 121
CHEITLIN, M., ARMSTRONG, W., AURIGEMMA, G., BELLER, G., BIERMAN, F., DAVIS, J., DOUGLAS, P., FAXON, D., GILLAM, L., & KIMBALL, T. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00685-0 · Cited by 107
Byhardt, R. W., Brace, K. C., Ruckdeschel, J. C., Chang, P., Martin, R., & Wiernik, P. H. (1975) · Cancer · Cited by 101
Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease
Constine, L. S., Schwartz, R. G., Savage, D. E., King, V., & Muhs, A. G. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00467-7 · Cited by 100
Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer.
Nielsen, D. L., Jensen, J. B., Dombernowsky, P., Munck, O., Fogh, J., Brynjolf, I., Havsteen, H., & Hansen, M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1806 · Cited by 99
Cardiac dysfunction following spinal irradiation during childhood.
Jakacki, R. I., Goldwein, J. W., Larsen, R. L., et al. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1033 · Cited by 86
Does anthracycline administration by infusion in children affect late cardiotoxicity?
Levitt, G., Dørup, I., Sørensen, K. E., & Sullivan, I. D. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04803.x · Cited by 85
Cardiovascular Trials in Long-Term Survivors of Childhood Cancer
Lipshultz, S. E., & Colan, S. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.937 · Cited by 85
Kapusta, L., THIJSSEN, J. M., Loonen, J. J., Antonius, T. A. J., Mulder, J., & Daniëls, O. (2000) · Ultrasound in Medicine & Biology · doi:10.1016/s0301-5629(00)00252-0 · Cited by 76
Diabetes mellitus after abdominal radiation therapy
Teinturier, C., Tournade, M. F., Caillat‐Zucman, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91461-7 · Cited by 61
Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy
Pınarlı, F. G., Oğuz, A., Tunaoglu, F. S., Karadeniz, C., Gökçora, N., & Elbeğ, Ş. (2004) · Pediatric Blood & Cancer · doi:10.1002/pbc.20281 · Cited by 54
Perel, R., Slaughter, R., & Strugnell, W. (2006) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640600737664 · Cited by 54
Silber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J. R., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowsky, M., et al. (2001) · American Heart Journal · doi:10.1067/mhj.2001.118115 · Cited by 39
Mathew, P., Suarez, W. A., Kip, K. T., Bayar, E., Jasty, R., Matloub, Y., & Raisch, D. W. (2001) · Cancer Investigation · doi:10.1081/cnv-100103130 · Cited by 34
The NCCN Guideline Program: a conceptual framework.
Winn, R., & Botnick, W. Z. (1997) · PubMed · Cited by 22
Cited by
Childhood and adolescent cancer statistics, 2014
Ward, E., DeSantis, C., Robbins, A., Kohler, B., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21219 · Cited by 2,412
Mertens, A. C., Liu, Q., Neglia, J. P., Wasilewski, K., Leisenring, W., Armstrong, G. T., Robison, L. L., & Yasui, Y. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn310 · Cited by 730
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Self-citationKalam, K., & Marwick, T. H. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.030 · Cited by 343
Seicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 326
Metadata
- Authors
- Shankar, S. M., Marina, N., Hudson, M. M., Hodgson, D. C., Adams, M. J., Landier, W., Bhatia, S., Meeske, K., Chen, M. H., Kinahan, K. E., Steinberger, J., & Rosenthal, D.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2008-02-01
- Volume
- 121
- Issue
- 2
- Pages
- e387-e396
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2081190745
- Cited by
- 283
- References
- 76
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.